On this page
FMR1
fragile X messenger ribonucleoprotein 1
The FMR1 gene provides instructions for making the FMRP protein, which is vital for proper brain development, synaptic plasticity, and is associated with several inherited conditions including Fragile X syndrome. The FMR1 gene encodes the fragile X messenger ribonucleoprotein (FMRP), a protein crucial for normal neurological function, particularly in the brain's synapses.
FMR1 is located on the long (q) arm of chromosome X, at band Xq27.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
The FMR1 gene, or fragile X messenger ribonucleoprotein 1, is essential for producing a protein called FMRP. This protein plays a significant role in the brain, where it helps in the development and function of connections between nerve cells, known as synapses. FMRP is particularly important for synaptic plasticity, which is the ability of synapses to change and adapt over time, a process fundamental for learning and memory.
While FMRP is found in various tissues, its precise role in areas outside the brain, such as the testes and ovaries, is less understood. Alterations in the FMR1 gene, especially expansions of a specific DNA segment, can lead to several conditions, including Fragile X syndrome, Fragile X-associated tremor/ataxia, and Fragile X-associated primary ovarian insufficiency.
What the gene does
The FMR1 gene directs the synthesis of the FMRP protein, which functions primarily as a shuttle within cells. It transports messenger RNA (mRNA) molecules from the nucleus to other parts of the cell where proteins are assembled. FMRP also helps regulate when the genetic instructions carried by these mRNA molecules are used to create proteins.
This regulatory role is crucial for nerve cell function, and potentially for the function of the testes and ovaries, though its exact mechanisms in reproductive tissues are still being investigated. The proper control of protein synthesis by FMRP is vital for maintaining healthy neuronal connections and overall brain development, underpinning processes like learning and memory.
Video: Genetics 101
Chromosome location
The FMR1 gene is located on the long arm of the X chromosome at position 27.3, designated as Xq27.3. This chromosomal location indicates its X-linked inheritance pattern.
Protein structure
The FMRP protein consists of 632 amino acids and contains several functional regions and domains. The region from amino acids 1-184 is required for nuclear localisation. It includes two Agenet-like domains: Agenet-like 1 (amino acids 4-50) and Agenet-like 2 (amino acids 63-115). Amino acids 172-211 are necessary for interaction with CYFIP1, CYFIP2, FXR1, and FXR2. Two KH domains, KH 1 (amino acids 222-251) and KH 2 (amino acids 285-314), are also present. The protein features disordered regions at amino acids 325-349 and 443-632. A region spanning amino acids 397-491 is required for nuclear export, containing a Nuclear export signal motif (amino acids 424-443). Interaction with RANBP9 occurs within the region from amino acids 419-632. Additionally, an RNA-binding RGG-box is found from amino acids 534-548, alongside two Nucleolar localization signal motifs at amino acids 527-534 and 613-617.
Key variants
The FMR1 gene contains a specific DNA segment with a repeating sequence of three DNA building blocks, CGG. The number of these CGG repeats typically ranges from fewer than 10 to about 40 in most individuals. Variations in the number of these repeats can lead to different classifications of alleles, from normal to premutation and full mutation, each associated with distinct clinical outcomes. Expansions in this trinucleotide repeat are the primary cause of FMR1-related conditions.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1062dup | p.His355fs | Pathogenic/Likely pathogenic | ★★☆☆ | Intellectual disability |
GRCh38/hg38 Xq27.3(chrX:147933767-147951004)x0 | - | Pathogenic | ★☆☆☆ | See cases |
g.(?_147030199)_(147046357_?)del | - | Pathogenic | ★☆☆☆ | Intellectual disability |
c.1375A>T | p.Lys459Ter | Pathogenic | ★☆☆☆ | Fragile X syndrome |
c.1411C>T | p.Arg471Ter | Pathogenic | ★☆☆☆ | not provided |
c.210_211dup | p.Ala71fs | Pathogenic | ★☆☆☆ | Fragile X syndrome |
c.420-8A>G | - | Pathogenic | ★☆☆☆ | Intellectual disability |
c.990+1G>A | - | Pathogenic | ★☆☆☆ | Intellectual disability |
c.990+1G>T | - | Pathogenic | ★☆☆☆ | not provided |
c.663del | p.Glu221fs | Pathogenic | - | Intellectual disability |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the FMR1 gene are primarily associated with a spectrum of conditions. These include Fragile X syndrome, which is caused by a significant expansion of CGG repeats leading to gene silencing. Smaller expansions, known as premutations, can cause Fragile X-associated tremor/ataxia syndrome (FXTAS) and Fragile X-associated primary ovarian insufficiency (FXPOI). The FMR1 gene is also associated with Premature ovarian insufficiency (genetic).
- Fragile X-associated primary ovarian insufficiency
- Fragile X-associated tremor/ataxia (FXTAS)
- Fragile X syndrome
- Premature ovarian insufficiency (genetic) Dedicated page coming soon
Inheritance pattern
Conditions caused by pathogenic FMR1 variants typically follow X-linked inheritance.
Carrier frequency by population How common is heterozygous FMR1 carrier status across ancestry groups?UK clinical status
The FMR1 gene is recognised in the UK as having clinical significance by the NHS Genomic Medicine Service. It is listed on PanelApp for its association with Intellectual disability and is included in the Developmental Disorders Genotype-Phenotype (DDG2P) panel, both categorised as 'green', indicating strong evidence for gene-disease association.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the FMR1 gene?
The FMR1 gene provides instructions for making a protein called FMRP, which is critical for normal brain development and the proper functioning of nerve cell connections (synapses). It plays an important role in learning and memory.
What conditions are associated with the FMR1 gene?
Variants in the FMR1 gene are linked to Fragile X syndrome, a common inherited cause of intellectual disability. It is also associated with Fragile X-associated tremor/ataxia syndrome (FXTAS) and Fragile X-associated primary ovarian insufficiency (FXPOI).
How do FMR1 variants affect the body?
Most FMR1-related conditions are caused by an expansion of a CGG trinucleotide repeat within the gene. This expansion can lead to a lack of the FMRP protein, impacting nerve cell communication, or it can cause the protein to function improperly, leading to a range of neurological and reproductive issues.
References
- Ma L, Herren AW, Espinal G. Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome. Acta neuropathologica communications. 2019. PMID: 31481131
- Kim K, Hessl D, Randol JL. Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions. PloS one. 2019. PMID: 31891607
- Hagerman RJ, Protic D, Rajaratnam A. Fragile X-Associated Neuropsychiatric Disorders (FXAND). Frontiers in psychiatry. 2018. PMID: 30483160
- Wang JY, Hessl D, Hagerman RJ. Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation. Neurobiology of aging. 2017. PMID: 28391068
- Wheeler A, Raspa M, Hagerman R. Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families. Pediatrics. 2017. PMID: 28814538
- Hagerman RJ, Berry-Kravis E, Hazlett HC. Fragile X syndrome. Nature reviews. Disease primers. 2017. PMID: 28960184
- Todd PK, Oh SY, Krans A. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 2013. PMID: 23602499
- Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. The Lancet. Neurology. 2013. PMID: 23867198
- Li Y, Jin P. RNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndrome. Brain research. 2012. PMID: 22459047
- Hessl D, Wang JM, Schneider A. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biological psychiatry. 2011. PMID: 21783174
- Hunsaker MR, Greco CM, Spath MA. Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta neuropathologica. 2011. PMID: 21785977
- Wittenberger MD, Hagerman RJ, Sherman SL. The FMR1 premutation and reproduction. Fertility and sterility. 2007. PMID: 17074338
- Tassone F, Beilina A, Carosi C. Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA (New York, N.Y.). 2007. PMID: 17283214
- Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Human genetics. 2005. PMID: 16078053
- Jacquemont S, Hagerman RJ, Leehey MA. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004. PMID: 14747503
- Adam MP, Bick S, Mirzaa GM. FMR1 Disorders. 1993. PMID: 20301558